The anti-allergic drug, N-(3',4'-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis.
OBJECTIVES: The degradation of tryptophan by indoleamine 2,3-dioxygenase yields a number of immunomodulatory metabolites, including 3-hydroxyanthranilic acid, 3-hydroxykynurenic acid and quinolinic acid. N-(3',4'-dimethoxycinnamonyl) anthranilic acid (3,4-DAA) is a synthetic anthranilic ac...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2007
|
| _version_ | 1797051895993335808 |
|---|---|
| author | Inglis, J Criado, G Andrews, M Feldmann, M Williams, R Selley, M |
| author_facet | Inglis, J Criado, G Andrews, M Feldmann, M Williams, R Selley, M |
| author_sort | Inglis, J |
| collection | OXFORD |
| description | OBJECTIVES: The degradation of tryptophan by indoleamine 2,3-dioxygenase yields a number of immunomodulatory metabolites, including 3-hydroxyanthranilic acid, 3-hydroxykynurenic acid and quinolinic acid. N-(3',4'-dimethoxycinnamonyl) anthranilic acid (3,4-DAA) is a synthetic anthranilic acid derivative that has been used therapeutically in Japan for many years as an anti-allergic drug and has recently been shown to be effective in a murine model of multiple sclerosis. METHODS: In the present study, we tested the efficacy of 3,4-DAA in collagen-induced arthritis, a mouse model of rheumatoid arthritis, and analysed its mechanism of action. RESULTS: Administration of 3,4-DAA after arthritis onset reduced clinical and histological severity of arthritis and reduced pain. It completely abrogated thermal and mechanical hyperalgesia. 3,4-DAA also suppressed Th1 cell activity in lymph node cell cultures and raised serum levels of IL-10. In vitro, 3,4-DAA suppressed IFNgamma production and proliferation of both T and B lymphocytes in a manner comparable with the endogenous tryptophan metabolite, 3-hydroxyanthranilic acid, suggesting similar mechanisms of action. CONCLUSION: It is concluded that 3,4-DAA has both anti-inflammatory and analgesic properties, and may therefore be useful in filling an unmet need, in the treatment of rheumatoid and other forms of arthritis, especially in the light of its analgesic properties. |
| first_indexed | 2024-03-06T18:25:47Z |
| format | Journal article |
| id | oxford-uuid:07e89386-a3af-44c9-a678-cc16f4e0863f |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T18:25:47Z |
| publishDate | 2007 |
| record_format | dspace |
| spelling | oxford-uuid:07e89386-a3af-44c9-a678-cc16f4e0863f2022-03-26T09:10:06ZThe anti-allergic drug, N-(3',4'-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:07e89386-a3af-44c9-a678-cc16f4e0863fEnglishSymplectic Elements at Oxford2007Inglis, JCriado, GAndrews, MFeldmann, MWilliams, RSelley, MOBJECTIVES: The degradation of tryptophan by indoleamine 2,3-dioxygenase yields a number of immunomodulatory metabolites, including 3-hydroxyanthranilic acid, 3-hydroxykynurenic acid and quinolinic acid. N-(3',4'-dimethoxycinnamonyl) anthranilic acid (3,4-DAA) is a synthetic anthranilic acid derivative that has been used therapeutically in Japan for many years as an anti-allergic drug and has recently been shown to be effective in a murine model of multiple sclerosis. METHODS: In the present study, we tested the efficacy of 3,4-DAA in collagen-induced arthritis, a mouse model of rheumatoid arthritis, and analysed its mechanism of action. RESULTS: Administration of 3,4-DAA after arthritis onset reduced clinical and histological severity of arthritis and reduced pain. It completely abrogated thermal and mechanical hyperalgesia. 3,4-DAA also suppressed Th1 cell activity in lymph node cell cultures and raised serum levels of IL-10. In vitro, 3,4-DAA suppressed IFNgamma production and proliferation of both T and B lymphocytes in a manner comparable with the endogenous tryptophan metabolite, 3-hydroxyanthranilic acid, suggesting similar mechanisms of action. CONCLUSION: It is concluded that 3,4-DAA has both anti-inflammatory and analgesic properties, and may therefore be useful in filling an unmet need, in the treatment of rheumatoid and other forms of arthritis, especially in the light of its analgesic properties. |
| spellingShingle | Inglis, J Criado, G Andrews, M Feldmann, M Williams, R Selley, M The anti-allergic drug, N-(3',4'-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis. |
| title | The anti-allergic drug, N-(3',4'-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis. |
| title_full | The anti-allergic drug, N-(3',4'-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis. |
| title_fullStr | The anti-allergic drug, N-(3',4'-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis. |
| title_full_unstemmed | The anti-allergic drug, N-(3',4'-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis. |
| title_short | The anti-allergic drug, N-(3',4'-dimethoxycinnamonyl) anthranilic acid, exhibits potent anti-inflammatory and analgesic properties in arthritis. |
| title_sort | anti allergic drug n 3 4 dimethoxycinnamonyl anthranilic acid exhibits potent anti inflammatory and analgesic properties in arthritis |
| work_keys_str_mv | AT inglisj theantiallergicdrugn34dimethoxycinnamonylanthranilicacidexhibitspotentantiinflammatoryandanalgesicpropertiesinarthritis AT criadog theantiallergicdrugn34dimethoxycinnamonylanthranilicacidexhibitspotentantiinflammatoryandanalgesicpropertiesinarthritis AT andrewsm theantiallergicdrugn34dimethoxycinnamonylanthranilicacidexhibitspotentantiinflammatoryandanalgesicpropertiesinarthritis AT feldmannm theantiallergicdrugn34dimethoxycinnamonylanthranilicacidexhibitspotentantiinflammatoryandanalgesicpropertiesinarthritis AT williamsr theantiallergicdrugn34dimethoxycinnamonylanthranilicacidexhibitspotentantiinflammatoryandanalgesicpropertiesinarthritis AT selleym theantiallergicdrugn34dimethoxycinnamonylanthranilicacidexhibitspotentantiinflammatoryandanalgesicpropertiesinarthritis AT inglisj antiallergicdrugn34dimethoxycinnamonylanthranilicacidexhibitspotentantiinflammatoryandanalgesicpropertiesinarthritis AT criadog antiallergicdrugn34dimethoxycinnamonylanthranilicacidexhibitspotentantiinflammatoryandanalgesicpropertiesinarthritis AT andrewsm antiallergicdrugn34dimethoxycinnamonylanthranilicacidexhibitspotentantiinflammatoryandanalgesicpropertiesinarthritis AT feldmannm antiallergicdrugn34dimethoxycinnamonylanthranilicacidexhibitspotentantiinflammatoryandanalgesicpropertiesinarthritis AT williamsr antiallergicdrugn34dimethoxycinnamonylanthranilicacidexhibitspotentantiinflammatoryandanalgesicpropertiesinarthritis AT selleym antiallergicdrugn34dimethoxycinnamonylanthranilicacidexhibitspotentantiinflammatoryandanalgesicpropertiesinarthritis |